A comparative study of peptide-based imaging agents [Ga]Ga-PSMA-11, [Ga]Ga-AMBA, [Ga]Ga-NODAGA-RGD and [Ga]Ga-DOTA-NT-20.3 in preclinical prostate tumour models.
Peptide-based imaging agents targeting prostate-specific membrane antigen (PSMA) have revolutionized the evaluation of biochemical recurrence of prostate cancer (PCa) but lacks sensitivity a...